CTVA
Corteva, Inc.
Company overview
- Market capitalization
- $51.87B
- Employees
- 21,500
- Latest publication
- 2026-09-29
About Corteva, Inc.
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. The company was founded in 1802 and is headquartered in Indianapolis, Indiana.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q2 20232023-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4,905,000,000USD | 3,910,000,000USD | 2,618,000,000USD | 6,456,000,000USD | 4,417,000,000USD | 2,326,000,000USD | 6,112,000,000USD | 6,045,000,000USD |
| Cost Of Revenue | 2,372,000,000USD | 2,254,000,000USD | 1,644,000,000USD | 2,932,000,000USD | 2,342,000,000USD | 1,565,000,000USD | 2,918,000,000USD | 3,137,000,000USD |
| Gross Profit | 2,533,000,000USD | — | 974,000,000USD | 3,524,000,000USD | 2,075,000,000USD | 761,000,000USD | 3,194,000,000USD | 2,908,000,000USD |
| Research Development | 341,000,000USD | 413,000,000USD | 351,000,000USD | 375,000,000USD | 335,000,000USD | 348,000,000USD | 357,000,000USD | 329,000,000USD |
| Selling General Administrative | 877,000,000USD | 860,000,000USD | 725,000,000USD | 1,156,000,000USD | 751,000,000USD | 671,000,000USD | 1,054,000,000USD | 1,075,000,000USD |
| Total Operating Expenses | 1,218,000,000USD | — | 1,076,000,000USD | 1,531,000,000USD | 1,086,000,000USD | 1,019,000,000USD | 1,585,000,000USD | 1,578,000,000USD |
| Operating Income | 1,315,000,000USD | — | -102,000,000USD | 1,993,000,000USD | 989,000,000USD | -258,000,000USD | 1,609,000,000USD | 1,330,000,000USD |
| Total Other Income Expense Net | -457,000,000USD | — | -268,000,000USD | -189,000,000USD | -205,000,000USD | -375,000,000USD | -271,000,000USD | -246,000,000USD |
| Interest Income | 34,000,000USD | — | 29,000,000USD | 31,000,000USD | 32,000,000USD | 33,000,000USD | 25,000,000USD | 54,000,000USD |
| Interest Expense | 36,000,000USD | — | — | 52,000,000USD | 36,000,000USD | 66,000,000USD | 66,000,000USD | 82,000,000USD |
| Income Before Tax | 858,000,000USD | — | -370,000,000USD | 1,804,000,000USD | 784,000,000USD | -633,000,000USD | 1,338,000,000USD | 1,084,000,000USD |
| Income Tax Expense | 133,000,000USD | — | -62,000,000USD | 422,000,000USD | 117,000,000USD | -114,000,000USD | 282,000,000USD | 204,000,000USD |
| Equity Method Income Loss | 16,000,000USD | — | -1,000,000USD | -1,000,000USD | 11,000,000USD | 0USD | — | — |
| Discontinued Operations | -2,000,000USD | — | -10,000,000USD | -66,000,000USD | -11,000,000USD | -2,000,000USD | — | -163,000,000USD |
| Net Income | 723,000,000USD | -549,000,000USD | -318,000,000USD | 1,316,000,000USD | 656,000,000USD | -521,000,000USD | 1,053,000,000USD | 714,000,000USD |
| Minority Interest | 3,000,000USD | — | 2,000,000USD | 2,000,000USD | 4,000,000USD | 3,000,000USD | -3,000,000USD | 3,000,000USD |
| Net Income Applicable To Common Shares | 720,000,000USD | — | -320,000,000USD | 1,314,000,000USD | 652,000,000USD | -524,000,000USD | — | 714,000,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | 36,000,000USD | — |
| Unclassified Operating Expenses | — | — | — | — | — | — | 138,000,000USD | 174,000,000USD |
| Net Interest Income | — | — | — | — | — | — | -41,000,000USD | -82,000,000USD |
| Tax Provision | — | — | — | — | — | — | 282,000,000USD | 204,000,000USD |
| Net Income From Continuing Ops | — | — | — | — | — | — | 1,056,000,000USD | 880,000,000USD |
| Ebit | — | — | — | — | — | — | 1,404,000,000USD | 1,166,000,000USD |
| Ebitda | — | — | — | — | — | — | 1,716,000,000USD | 1,472,000,000USD |
| Depreciation And Amortization | — | — | — | — | — | — | 312,000,000USD | 306,000,000USD |
| Reconciled Depreciation | — | — | — | — | — | — | 312,000,000USD | 306,000,000USD |
| Source | DisclosureDeterministicFinal | DisclosurePreliminary | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|
| Total Revenue | 17,401,000,000USD | 16,908,000,000USD | 17,455,000,000USD | 15,655,000,000USD |
| Cost Of Revenue | 9,172,000,000USD | 9,529,000,000USD | 10,436,000,000USD | 9,220,000,000USD |
| Gross Profit | 8,229,000,000USD | 7,379,000,000USD | 7,019,000,000USD | 6,435,000,000USD |
| Research Development | 1,474,000,000USD | 1,402,000,000USD | 1,216,000,000USD | 1,187,000,000USD |
| Selling General Administrative | 3,492,000,000USD | 3,196,000,000USD | 3,173,000,000USD | 3,209,000,000USD |
| Total Operating Expenses | 4,966,000,000USD | 4,598,000,000USD | 5,091,000,000USD | 5,118,000,000USD |
| Operating Income | 3,263,000,000USD | 2,781,000,000USD | 1,928,000,000USD | 1,317,000,000USD |
| Total Other Income Expense Net | -1,575,000,000USD | -1,506,000,000USD | -502,000,000USD | 1,029,000,000USD |
| Interest Income | 136,000,000USD | 132,000,000USD | 124,000,000USD | 77,000,000USD |
| Interest Expense | 180,000,000USD | 233,000,000USD | 79,000,000USD | 30,000,000USD |
| Income Before Tax | 1,688,000,000USD | 1,275,000,000USD | 1,426,000,000USD | 2,346,000,000USD |
| Income Tax Expense | 484,000,000USD | 412,000,000USD | 210,000,000USD | 524,000,000USD |
| Equity Method Income Loss | 13,000,000USD | 15,000,000USD | — | — |
| Discontinued Operations | -99,000,000USD | 56,000,000USD | -58,000,000USD | -53,000,000USD |
| Net Income | 1,105,000,000USD | 919,000,000USD | 1,147,000,000USD | 1,759,000,000USD |
| Minority Interest | 11,000,000USD | 12,000,000USD | -11,000,000USD | -10,000,000USD |
| Net Income Applicable To Common Shares | 1,094,000,000USD | 907,000,000USD | 1,147,000,000USD | 1,759,000,000USD |
| Litigation Settlement Expense | — | 101,000,000USD | — | — |
| Unclassified Operating Expenses | — | — | 702,000,000USD | 722,000,000USD |
| Net Interest Income | — | — | -79,000,000USD | -30,000,000USD |
| Tax Provision | — | — | 210,000,000USD | 524,000,000USD |
| Net Income From Continuing Ops | — | — | 1,216,000,000USD | 1,822,000,000USD |
| Ebit | — | — | 1,505,000,000USD | 2,376,000,000USD |
| Ebitda | — | — | 2,728,000,000USD | 3,619,000,000USD |
| Depreciation And Amortization | — | — | 1,223,000,000USD | 1,243,000,000USD |
| Reconciled Depreciation | — | — | 1,223,000,000USD | 1,243,000,000USD |
| Non Operating Income Net Other | — | — | -60,000,000USD | 1,348,000,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 42,717,000,000USD | 42,845,000,000USD | 42,198,000,000USD | 41,759,000,000USD | 42,123,000,000USD | 40,825,000,000USD | 41,908,000,000USD | 41,464,000,000USD |
| Cash And Equivalents | 1,964,000,000USD | 4,521,000,000USD | 2,509,000,000USD | 2,065,000,000USD | 2,008,000,000USD | 3,106,000,000USD | 2,421,000,000USD | — |
| Cash And Short Term Investments | 1,966,000,000USD | 4,530,000,000USD | 2,586,000,000USD | 2,141,000,000USD | 2,009,000,000USD | 3,169,000,000USD | 2,493,000,000USD | 1,959,000,000USD |
| Short Term Investments | 2,000,000USD | 9,000,000USD | 77,000,000USD | 76,000,000USD | 1,000,000USD | 63,000,000USD | 72,000,000USD | 120,000,000USD |
| Total Current Assets | 17,385,000,000USD | 17,335,000,000USD | 16,438,000,000USD | 16,004,000,000USD | 16,587,000,000USD | 15,097,000,000USD | 15,649,000,000USD | 15,359,000,000USD |
| Other Current Assets | 1,129,000,000USD | 767,000,000USD | 758,000,000USD | 873,000,000USD | 1,152,000,000USD | 820,000,000USD | 831,000,000USD | 892,000,000USD |
| Other Non Current Assets | 2,033,000,000USD | 2,044,000,000USD | 2,043,000,000USD | 1,918,000,000USD | 1,832,000,000USD | 1,810,000,000USD | 1,644,000,000USD | — |
| Total Liabilities | 18,112,000,000USD | 18,459,000,000USD | 16,737,000,000USD | 15,608,000,000USD | 17,596,000,000USD | 16,795,000,000USD | 16,929,000,000USD | — |
| Total Current Liabilities | 11,854,000,000USD | 12,125,000,000USD | 10,420,000,000USD | 9,516,000,000USD | 11,481,000,000USD | 10,386,000,000USD | 10,424,000,000USD | 8,953,000,000USD |
| Other Current Liabilities | 2,991,000,000USD | 3,099,000,000USD | 2,661,000,000USD | 2,903,000,000USD | 2,332,000,000USD | 2,103,000,000USD | 2,188,000,000USD | — |
| Other Non Current Liabilities | 1,898,000,000USD | 1,963,000,000USD | 2,041,000,000USD | 1,918,000,000USD | 1,715,000,000USD | 1,707,000,000USD | 1,561,000,000USD | — |
| Total Stockholder Equity | 24,362,000,000USD | 24,144,000,000USD | 25,219,000,000USD | 25,909,000,000USD | 24,285,000,000USD | 23,789,000,000USD | 24,737,000,000USD | 25,179,000,000USD |
| Total Equity Including Noncontrolling Interest | 24,605,000,000USD | 24,386,000,000USD | 25,461,000,000USD | 26,151,000,000USD | 24,527,000,000USD | 24,030,000,000USD | 24,979,000,000USD | — |
| Short Long Term Debt | 1,582,000,000USD | 1,564,000,000USD | 1,576,000,000USD | 2,566,000,000USD | 1,346,000,000USD | 1,000,000,000USD | 1,000,000,000USD | 2,252,000,000USD |
| Long Term Debt | 1,682,000,000USD | 1,686,000,000USD | 1,688,000,000USD | 1,687,000,000USD | 1,792,000,000USD | 1,953,000,000USD | 1,975,000,000USD | 2,471,000,000USD |
| Deferred Revenue | 2,773,000,000USD | 3,579,000,000USD | 483,000,000USD | 358,000,000USD | 2,631,000,000USD | 3,287,000,000USD | — | — |
| Deferred Revenue Non Current | 113,000,000USD | 125,000,000USD | 123,000,000USD | 118,000,000USD | 111,000,000USD | 114,000,000USD | — | — |
| Net Receivables | 7,262,000,000USD | 4,881,000,000USD | 5,050,000,000USD | 5,961,000,000USD | 6,765,000,000USD | 4,448,000,000USD | 4,260,000,000USD | 7,615,000,000USD |
| Inventory | 5,202,000,000USD | 5,667,000,000USD | 5,310,000,000USD | 4,316,000,000USD | 5,132,000,000USD | 5,432,000,000USD | 5,674,000,000USD | 4,893,000,000USD |
| Property Plant Equipment Net | 4,183,000,000USD | 4,631,000,000USD | 4,202,000,000USD | 4,153,000,000USD | 4,105,000,000USD | 4,513,000,000USD | 4,210,000,000USD | 4,155,000,000USD |
| Goodwill | 10,409,000,000USD | 10,465,000,000USD | 10,512,000,000USD | 10,518,000,000USD | 10,332,000,000USD | 10,408,000,000USD | 10,629,000,000USD | — |
| Intangible Assets | 8,147,000,000USD | 8,301,000,000USD | 8,428,000,000USD | 8,583,000,000USD | 8,718,000,000USD | 8,876,000,000USD | 9,084,000,000USD | 9,238,000,000USD |
| Accounts Payable | 4,187,000,000USD | 4,398,000,000USD | 4,337,000,000USD | 3,828,000,000USD | 3,905,000,000USD | 4,039,000,000USD | 3,753,000,000USD | 3,300,000,000USD |
| Short Term Debt | 1,674,000,000USD | 894,000,000USD | 2,685,000,000USD | 1,942,000,000USD | 2,291,000,000USD | 750,000,000USD | 3,741,000,000USD | 2,253,000,000USD |
| Common Stock | 7,000,000USD | 7,000,000USD | 7,000,000USD | 7,000,000USD | 7,000,000USD | 7,000,000USD | 7,000,000USD | 7,000,000USD |
| Retained Earnings | 436,000,000USD | -67,000,000USD | 834,000,000USD | 1,532,000,000USD | 587,000,000USD | 55,000,000USD | 98,000,000USD | 992,000,000USD |
| Accumulated Other Comprehensive Income | -2,940,000,000USD | -2,797,000,000USD | -2,661,000,000USD | -2,644,000,000USD | -3,271,000,000USD | -3,469,000,000USD | -2,886,000,000USD | -3,324,000,000USD |
| Total Liab | — | — | — | — | — | — | — | 16,043,000,000USD |
| Other Current Liab | — | — | — | — | — | — | — | 2,499,000,000USD |
| Capital Stock | — | — | — | — | — | — | — | 7,000,000USD |
| Good Will | — | — | — | — | — | — | — | 10,490,000,000USD |
| Cash | — | — | — | — | — | — | — | 1,839,000,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | 413,000,000USD |
| Net Debt | — | — | — | — | — | — | — | 2,885,000,000USD |
| Short Long Term Debt Total | — | — | — | — | — | — | — | 4,724,000,000USD |
| Long Term Investments | — | — | — | — | — | — | — | 113,000,000USD |
| Property Plant Equipment Gross | — | — | — | — | — | — | — | 9,088,000,000USD |
| Common Stock Shares Outstanding | — | — | — | — | — | — | — | 698,100,000shares |
| Non Current Assets Total | — | — | — | — | — | — | — | 26,105,000,000USD |
| Non Current Liabilities Total | — | — | — | — | — | — | — | 7,090,000,000USD |
| Non Current Liabilities Other | — | — | — | — | — | — | — | 1,560,000,000USD |
| Non Currrent Assets Other | — | — | — | — | — | — | — | 1,571,000,000USD |
| Net Working Capital | — | — | — | — | — | — | — | 6,406,000,000USD |
| Unclassified Non Current Assets | — | — | — | — | — | — | — | 538,000,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | — | -1,764,000,000USD |
| Unclassified Non Current Liabilities | — | — | — | — | — | — | — | 3,059,000,000USD |
| Unclassified Equity | — | — | — | — | — | — | — | 27,497,000,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 42,845,000,000USD | 40,825,000,000USD | 42,996,000,000USD | 42,618,000,000USD | 42,344,000,000USD | 42,649,000,000USD | 42,397,000,000USD | 42,880,000,000USD |
| Cash And Equivalents | 4,521,000,000USD | 3,106,000,000USD | — | — | — | — | — | — |
| Cash And Short Term Investments | 4,530,000,000USD | 3,169,000,000USD | 2,742,000,000USD | 3,315,000,000USD | 4,545,000,000USD | 3,795,000,000USD | 1,769,000,000USD | 2,133,000,000USD |
| Short Term Investments | 9,000,000USD | 63,000,000USD | 98,000,000USD | 124,000,000USD | 86,000,000USD | 269,000,000USD | 5,000,000USD | 5,000,000USD |
| Total Current Assets | 17,335,000,000USD | 15,097,000,000USD | 16,260,000,000USD | 16,795,000,000USD | 15,546,000,000USD | 14,768,000,000USD | 13,519,000,000USD | 13,836,000,000USD |
| Other Current Assets | 767,000,000USD | 820,000,000USD | 1,131,000,000USD | 968,000,000USD | 1,010,000,000USD | 1,165,000,000USD | 1,190,000,000USD | 1,044,000,000USD |
| Other Non Current Assets | 2,044,000,000USD | 1,810,000,000USD | — | — | — | — | — | — |
| Total Liabilities | 18,459,000,000USD | 16,795,000,000USD | — | — | — | — | — | — |
| Total Current Liabilities | 12,125,000,000USD | 10,386,000,000USD | 10,409,000,000USD | 10,744,000,000USD | 9,558,000,000USD | 8,548,000,000USD | 8,238,000,000USD | 9,994,000,000USD |
| Other Current Liabilities | 3,099,000,000USD | 2,103,000,000USD | — | — | — | — | — | — |
| Other Non Current Liabilities | 1,963,000,000USD | 1,707,000,000USD | — | — | — | — | — | — |
| Total Stockholder Equity | 24,144,000,000USD | 23,789,000,000USD | 25,037,000,000USD | 25,302,000,000USD | 25,384,000,000USD | 24,824,000,000USD | 24,309,000,000USD | 23,824,000,000USD |
| Total Equity Including Noncontrolling Interest | 24,386,000,000USD | 24,030,000,000USD | — | — | — | — | — | — |
| Short Long Term Debt | 1,564,000,000USD | 1,000,000,000USD | 197,000,000USD | 24,000,000USD | 17,000,000USD | 3,000,000USD | 3,000,000USD | 1,889,000,000USD |
| Long Term Debt | 1,686,000,000USD | 1,953,000,000USD | 2,291,000,000USD | 1,283,000,000USD | 1,100,000,000USD | 1,102,000,000USD | 110,000,000USD | 179,000,000USD |
| Deferred Revenue | 3,579,000,000USD | 3,287,000,000USD | — | — | — | — | — | — |
| Deferred Revenue Non Current | 125,000,000USD | 114,000,000USD | — | — | — | — | — | — |
| Net Receivables | 4,881,000,000USD | 4,448,000,000USD | 5,488,000,000USD | 5,701,000,000USD | 4,811,000,000USD | 4,926,000,000USD | 5,528,000,000USD | 5,409,000,000USD |
| Inventory | 5,667,000,000USD | 5,432,000,000USD | 6,899,000,000USD | 6,811,000,000USD | 5,180,000,000USD | 4,882,000,000USD | 5,032,000,000USD | 5,250,000,000USD |
| Property Plant Equipment Net | 4,631,000,000USD | 4,513,000,000USD | 4,287,000,000USD | 4,254,000,000USD | 4,329,000,000USD | 4,396,000,000USD | 4,546,000,000USD | 4,533,000,000USD |
| Goodwill | 10,465,000,000USD | 10,408,000,000USD | — | — | — | — | — | — |
| Intangible Assets | 8,301,000,000USD | 8,876,000,000USD | 9,626,000,000USD | 9,339,000,000USD | 10,044,000,000USD | 10,747,000,000USD | 11,424,000,000USD | 12,055,000,000USD |
| Accounts Payable | 4,398,000,000USD | 4,039,000,000USD | 4,280,000,000USD | 4,895,000,000USD | 4,126,000,000USD | 3,615,000,000USD | 3,702,000,000USD | 3,783,000,000USD |
| Short Term Debt | 894,000,000USD | 750,000,000USD | 198,000,000USD | 24,000,000USD | 17,000,000USD | 4,000,000USD | 7,000,000USD | 1,889,000,000USD |
| Common Stock | 7,000,000USD | 7,000,000USD | 7,000,000USD | 7,000,000USD | 7,000,000USD | 7,000,000USD | 7,000,000USD | 7,000,000USD |
| Retained Earnings | -67,000,000USD | 55,000,000USD | -41,000,000USD | 250,000,000USD | 524,000,000USD | 0USD | -425,000,000USD | -1,000,000USD |
| Accumulated Other Comprehensive Income | -2,797,000,000USD | -3,469,000,000USD | -2,677,000,000USD | -2,806,000,000USD | -2,898,000,000USD | -2,890,000,000USD | -3,270,000,000USD | -2,412,000,000USD |
| Total Liab | — | — | 17,717,000,000USD | 17,077,000,000USD | 16,721,000,000USD | 17,586,000,000USD | 17,842,000,000USD | 19,056,000,000USD |
| Other Current Liab | — | — | 2,351,000,000USD | 2,254,000,000USD | 2,068,000,000USD | 2,144,000,000USD | 1,850,000,000USD | 4,173,000,000USD |
| Capital Stock | — | — | 7,000,000USD | 7,000,000USD | 7,000,000USD | 7,000,000USD | 7,000,000USD | 7,000,000USD |
| Good Will | — | — | 10,605,000,000USD | 9,962,000,000USD | 10,107,000,000USD | 10,269,000,000USD | 10,229,000,000USD | 10,193,000,000USD |
| Cash | — | — | 2,644,000,000USD | 3,191,000,000USD | 4,459,000,000USD | 3,526,000,000USD | 1,764,000,000USD | 2,128,000,000USD |
| Current Deferred Revenue | — | — | 3,406,000,000USD | 3,388,000,000USD | 3,201,000,000USD | 2,662,000,000USD | 2,584,000,000USD | 149,000,000USD |
| Net Debt | — | — | -155,000,000USD | -1,884,000,000USD | -3,339,000,000USD | -2,420,000,000USD | -1,637,000,000USD | -60,000,000USD |
| Short Long Term Debt Total | — | — | 2,489,000,000USD | 1,307,000,000USD | 1,120,000,000USD | 1,106,000,000USD | 127,000,000USD | 7,673,000,000USD |
| Long Term Investments | — | — | 115,000,000USD | 102,000,000USD | 76,000,000USD | 66,000,000USD | 66,000,000USD | 138,000,000USD |
| Property Plant Equipment Gross | — | — | 8,956,000,000USD | 4,254,000,000USD | 4,329,000,000USD | 4,396,000,000USD | 4,546,000,000USD | 4,533,000,000USD |
| Common Stock Shares Outstanding | — | — | 711,900,000shares | 724,500,000shares | 741,600,000shares | 751,200,000shares | 749,500,000shares | 749,400,000shares |
| Non Current Assets Total | — | — | 26,736,000,000USD | 25,823,000,000USD | 26,798,000,000USD | 27,881,000,000USD | 28,878,000,000USD | 29,044,000,000USD |
| Non Current Liabilities Total | — | — | 7,308,000,000USD | 6,333,000,000USD | 7,163,000,000USD | 9,038,000,000USD | 9,604,000,000USD | 9,062,000,000USD |
| Non Current Liabilities Other | — | — | 1,651,000,000USD | 1,676,000,000USD | 1,719,000,000USD | 5,176,000,000USD | 2,192,000,000USD | 1,777,000,000USD |
| Non Currrent Assets Other | — | — | 1,519,000,000USD | 1,687,000,000USD | 1,804,000,000USD | 1,939,000,000USD | 2,326,000,000USD | 1,830,000,000USD |
| Net Working Capital | — | — | 5,851,000,000USD | 6,051,000,000USD | 5,988,000,000USD | 6,220,000,000USD | 5,281,000,000USD | 3,842,000,000USD |
| Unclassified Non Current Assets | — | — | 584,000,000USD | -1,227,000,000USD | -1,804,000,000USD | -1,939,000,000USD | -1,771,000,000USD | -58,486,000,000USD |
| Unclassified Non Current Liabilities | — | — | 3,366,000,000USD | -2,464,000,000USD | -2,939,000,000USD | -6,069,000,000USD | -1,761,000,000USD | -7,335,000,000USD |
| Unclassified Equity | — | — | 27,741,000,000USD | 27,844,000,000USD | 27,744,000,000USD | 27,700,000,000USD | 27,990,000,000USD | 26,223,000,000USD |
| Deferred Long Term Liab | — | — | — | 1,119,000,000USD | 1,220,000,000USD | 893,000,000USD | — | 5,000,000USD |
| Other Liab | — | — | — | 4,719,000,000USD | 6,063,000,000USD | 7,936,000,000USD | 9,063,000,000USD | 14,436,000,000USD |
| Other Assets | — | — | — | 1,706,000,000USD | 2,242,000,000USD | 2,403,000,000USD | 2,058,000,000USD | 58,781,000,000USD |
| Net Tangible Assets | — | — | — | 25,302,000,000USD | 5,233,000,000USD | 24,824,000,000USD | 2,656,000,000USD | 52,412,000,000USD |
| Unclassified Current Liabilities | — | — | — | 159,000,000USD | 129,000,000USD | 120,000,000USD | 92,000,000USD | -1,889,000,000USD |
| Additional Paid In Capital | — | — | — | — | — | — | — | 0USD |
| Treasury Stock | — | — | — | — | — | — | — | 0USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 297,000,000USD | 306,000,000USD | 300,000,000USD | 301,000,000USD | 296,000,000USD | 302,000,000USD | 306,000,000USD | 312,000,000USD |
| Deferred Income Tax | -35,000,000USD | — | — | — | -122,000,000USD | — | — | — |
| Other Non Cash Items | -157,000,000USD | 157,000,000USD | 208,000,000USD | 224,000,000USD | -75,000,000USD | 114,000,000USD | 180,000,000USD | 30,000,000USD |
| Change To Account Receivables | -2,810,000,000USD | 1,398,000,000USD | 885,000,000USD | -39,000,000USD | -2,505,000,000USD | 745,000,000USD | 977,000,000USD | 119,000,000USD |
| Change To Inventory | 439,000,000USD | -366,000,000USD | -979,000,000USD | 931,000,000USD | 379,000,000USD | 50,000,000USD | -723,000,000USD | 1,165,000,000USD |
| Change To Liabilities | -221,000,000USD | — | — | — | -190,000,000USD | — | — | — |
| Change In Working Capital | -3,382,000,000USD | 4,464,000,000USD | -57,000,000USD | -873,000,000USD | -2,983,000,000USD | 3,752,000,000USD | 285,000,000USD | -793,000,000USD |
| Operating Cash Flow | -2,891,000,000USD | — | — | — | -2,109,000,000USD | — | — | — |
| Capital Expenditures | -81,000,000USD | -222,000,000USD | -157,000,000USD | -118,000,000USD | -94,000,000USD | -181,000,000USD | -154,000,000USD | -114,000,000USD |
| Net Investments | 8,000,000USD | — | — | — | 62,000,000USD | — | — | — |
| Other Investing Activities | 1,000,000USD | — | — | — | 10,000,000USD | — | — | — |
| Unclassified Investing Cash Flow | -5,000,000USD | -13,000,000USD | 146,000,000USD | 125,000,000USD | -12,000,000USD | 179,000,000USD | 203,000,000USD | 104,000,000USD |
| Investing Cash Flow | -77,000,000USD | — | — | — | -34,000,000USD | — | — | — |
| Net Debt Issuance | 767,000,000USD | — | — | — | 1,368,000,000USD | — | — | — |
| Net Common Stock Issuance | -250,000,000USD | — | — | — | -270,000,000USD | — | — | — |
| Common Dividends Paid | -121,000,000USD | — | — | — | -116,000,000USD | — | — | — |
| Other Financing Activities | -24,000,000USD | — | — | — | -22,000,000USD | — | — | — |
| Unclassified Financing Cash Flow | 17,000,000USD | — | 5,000,000USD | — | 35,000,000USD | — | — | 123,000,000USD |
| Financing Cash Flow | 389,000,000USD | — | — | — | 995,000,000USD | — | — | — |
| Effect Of Forex Changes On Cash | -5,000,000USD | — | — | — | 21,000,000USD | — | — | — |
| Change In Cash | -2,584,000,000USD | 1,784,000,000USD | 420,000,000USD | 22,000,000USD | -1,127,000,000USD | 666,000,000USD | 615,000,000USD | 127,000,000USD |
| End Cash Flow | 2,141,000,000USD | — | — | — | 2,295,000,000USD | — | — | — |
| Net Income | — | -552,000,000USD | -395,000,000USD | 1,382,000,000USD | — | -52,000,000USD | -522,000,000USD | 1,053,000,000USD |
| Total Cash From Operating Activities | — | 4,375,000,000USD | 193,000,000USD | 947,000,000USD | — | 4,173,000,000USD | 130,000,000USD | 451,000,000USD |
| Free Cash Flow | — | 4,153,000,000USD | 36,000,000USD | 829,000,000USD | — | 3,992,000,000USD | -24,000,000USD | 337,000,000USD |
| Investments | — | 40,000,000USD | -157,000,000USD | -164,000,000USD | — | -123,000,000USD | -161,000,000USD | -35,000,000USD |
| Total Cashflows From Investing Activities | — | -188,000,000USD | -157,000,000USD | -164,000,000USD | — | -123,000,000USD | -161,000,000USD | -35,000,000USD |
| Net Borrowings | — | -1,787,000,000USD | 739,000,000USD | -461,000,000USD | — | -2,993,000,000USD | 989,000,000USD | — |
| Total Cash From Financing Activities | — | -2,198,000,000USD | 367,000,000USD | -808,000,000USD | — | -3,336,000,000USD | 619,000,000USD | -248,000,000USD |
| Dividends Paid | — | -121,000,000USD | -122,000,000USD | -116,000,000USD | — | -118,000,000USD | -117,000,000USD | -111,000,000USD |
| Sale Purchase Of Stock | — | -301,000,000USD | -250,000,000USD | -250,000,000USD | — | -252,000,000USD | -253,000,000USD | -252,000,000USD |
| Begin Period Cash Flow | — | 2,737,000,000USD | 2,317,000,000USD | 2,295,000,000USD | — | 2,756,000,000USD | 2,141,000,000USD | 2,014,000,000USD |
| End Period Cash Flow | — | 4,521,000,000USD | 2,737,000,000USD | 2,317,000,000USD | — | 3,422,000,000USD | 2,756,000,000USD | 2,141,000,000USD |
| Other Cashflows From Investing Activities | — | 7,000,000USD | 11,000,000USD | -7,000,000USD | — | 2,000,000USD | -49,000,000USD | 10,000,000USD |
| Other Cashflows From Financing Activities | — | -2,000,000USD | -5,000,000USD | 19,000,000USD | — | -3,000,000USD | -2,000,000USD | -8,000,000USD |
| Unclassified Operating Cash Flow | — | — | 137,000,000USD | -87,000,000USD | — | 57,000,000USD | -119,000,000USD | -151,000,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 1,203,000,000USD | 1,227,000,000USD | 1,211,000,000USD | 1,223,000,000USD | 1,243,000,000USD | 1,177,000,000USD | 1,599,000,000USD | 2,790,000,000USD |
| Deferred Income Tax | -41,000,000USD | -365,000,000USD | — | — | — | — | — | — |
| Other Non Cash Items | -545,000,000USD | -383,000,000USD | 841,000,000USD | 326,000,000USD | 198,000,000USD | 563,000,000USD | 736,000,000USD | 5,669,000,000USD |
| Change To Inventory | -35,000,000USD | 1,110,000,000USD | 57,000,000USD | -1,715,000,000USD | -422,000,000USD | 104,000,000USD | 74,000,000USD | -498,000,000USD |
| Change To Liabilities | 231,000,000USD | -115,000,000USD | — | 807,000,000USD | 524,000,000USD | -118,000,000USD | 149,000,000USD | 642,000,000USD |
| Change In Working Capital | 466,000,000USD | 909,000,000USD | -786,000,000USD | -1,549,000,000USD | 656,000,000USD | 359,000,000USD | -556,000,000USD | -2,942,000,000USD |
| Operating Cash Flow | 3,406,000,000USD | 2,145,000,000USD | — | — | — | — | — | — |
| Capital Expenditures | -591,000,000USD | -597,000,000USD | -595,000,000USD | -605,000,000USD | -573,000,000USD | -475,000,000USD | -1,163,000,000USD | -1,501,000,000USD |
| Net Investments | 135,000,000USD | -14,000,000USD | — | — | — | — | — | — |
| Other Investing Activities | 38,000,000USD | 39,000,000USD | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | -125,000,000USD | -17,000,000USD | 529,000,000USD | 535,000,000USD | 75,000,000USD | — | 1,176,000,000USD | 1,426,000,000USD |
| Investing Cash Flow | -543,000,000USD | -589,000,000USD | — | — | — | — | — | — |
| Net Debt Issuance | -141,000,000USD | 239,000,000USD | — | — | — | — | — | — |
| Net Common Stock Issuance | -1,071,000,000USD | -1,009,000,000USD | — | — | — | — | — | — |
| Common Dividends Paid | -475,000,000USD | -458,000,000USD | — | — | — | — | — | — |
| Other Financing Activities | -45,000,000USD | -32,000,000USD | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | 88,000,000USD | 61,000,000USD | — | -1,039,000,000USD | 100,000,000USD | -1,385,000,000USD | 47,000,000USD | -85,000,000USD |
| Financing Cash Flow | -1,644,000,000USD | -1,199,000,000USD | — | — | — | — | — | — |
| Effect Of Forex Changes On Cash | 84,000,000USD | -93,000,000USD | — | — | — | — | — | — |
| Change In Cash | 1,303,000,000USD | 264,000,000USD | -460,000,000USD | -1,218,000,000USD | 963,000,000USD | 1,700,000,000USD | -2,851,000,000USD | -2,890,000,000USD |
| End Cash Flow | 4,725,000,000USD | 3,422,000,000USD | — | — | — | — | — | — |
| Net Income | — | — | 941,000,000USD | 1,158,000,000USD | 1,769,000,000USD | 701,000,000USD | -941,000,000USD | -5,065,000,000USD |
| Stock Based Compensation | — | — | 54,000,000USD | 55,000,000USD | -1,313,000,000USD | -406,000,000USD | 709,000,000USD | 4,252,000,000USD |
| Change To Account Receivables | — | — | 358,000,000USD | -997,000,000USD | -113,000,000USD | 187,000,000USD | -361,000,000USD | -1,522,000,000USD |
| Total Cash From Operating Activities | — | — | 1,769,000,000USD | 872,000,000USD | 2,727,000,000USD | 2,064,000,000USD | 1,070,000,000USD | 483,000,000USD |
| Free Cash Flow | — | — | 1,174,000,000USD | 267,000,000USD | 2,154,000,000USD | 1,589,000,000USD | -93,000,000USD | -1,018,000,000USD |
| Investments | — | — | -1,966,000,000USD | -632,000,000USD | 137,000,000USD | -275,000,000USD | -904,000,000USD | -505,000,000USD |
| Total Cashflows From Investing Activities | — | — | -1,987,000,000USD | -632,000,000USD | -362,000,000USD | -674,000,000USD | -904,000,000USD | -505,000,000USD |
| Net Borrowings | — | — | 1,114,000,000USD | -13,000,000USD | 11,000,000USD | 2,439,000,000USD | -7,671,000,000USD | -4,800,000,000USD |
| Total Cash From Financing Activities | — | — | -99,000,000USD | -1,180,000,000USD | -1,266,000,000USD | 303,000,000USD | -2,929,000,000USD | -2,624,000,000USD |
| Dividends Paid | — | — | -439,000,000USD | -418,000,000USD | -397,000,000USD | -388,000,000USD | -511,000,000USD | -2,806,000,000USD |
| Sale Purchase Of Stock | — | — | -756,000,000USD | -1,000,000,000USD | -950,000,000USD | -275,000,000USD | -25,000,000USD | 85,000,000USD |
| Begin Period Cash Flow | — | — | 3,618,000,000USD | 4,836,000,000USD | 3,873,000,000USD | 2,173,000,000USD | 5,024,000,000USD | 7,914,000,000USD |
| End Period Cash Flow | — | — | 3,158,000,000USD | 3,618,000,000USD | 4,836,000,000USD | 3,873,000,000USD | 2,173,000,000USD | 5,024,000,000USD |
| Other Cashflows From Investing Activities | — | — | 45,000,000USD | 70,000,000USD | -1,000,000USD | 76,000,000USD | -13,000,000USD | 75,000,000USD |
| Other Cashflows From Financing Activities | — | — | -18,000,000USD | 1,290,000,000USD | -30,000,000USD | -88,000,000USD | 5,231,000,000USD | 4,982,000,000USD |
| Unclassified Operating Cash Flow | — | — | -492,000,000USD | -341,000,000USD | 174,000,000USD | -330,000,000USD | -477,000,000USD | -4,221,000,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -940,000,000USD | 1,099,000,000USD | 1,693,000,000USD | — | — |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|
| Depreciation | 897,000,000USD | 597,000,000USD | 925,000,000USD |
| Deferred Income Tax | -72,000,000USD | -209,000,000USD | -422,000,000USD |
| Other Non Cash Items | -386,000,000USD | -272,000,000USD | -377,000,000USD |
| Change To Account Receivables | -1,659,000,000USD | -2,544,000,000USD | -1,450,000,000USD |
| Change To Inventory | 331,000,000USD | 1,310,000,000USD | 1,060,000,000USD |
| Change To Liabilities | 123,000,000USD | -356,000,000USD | -518,000,000USD |
| Change In Working Capital | -4,029,000,000USD | -4,534,000,000USD | -3,882,000,000USD |
| Operating Cash Flow | -969,000,000USD | -1,162,000,000USD | -2,028,000,000USD |
| Capital Expenditures | -369,000,000USD | -212,000,000USD | -416,000,000USD |
| Net Investments | 68,000,000USD | 62,000,000USD | -22,000,000USD |
| Other Investing Activities | 17,000,000USD | 17,000,000USD | 38,000,000USD |
| Unclassified Investing Cash Flow | -71,000,000USD | -65,000,000USD | -66,000,000USD |
| Investing Cash Flow | -355,000,000USD | -198,000,000USD | -466,000,000USD |
| Net Debt Issuance | 1,646,000,000USD | 907,000,000USD | 3,233,000,000USD |
| Net Common Stock Issuance | -770,000,000USD | -520,000,000USD | -757,000,000USD |
| Common Dividends Paid | -354,000,000USD | -232,000,000USD | -340,000,000USD |
| Other Financing Activities | -43,000,000USD | -38,000,000USD | -29,000,000USD |
| Unclassified Financing Cash Flow | 75,000,000USD | 70,000,000USD | 30,000,000USD |
| Financing Cash Flow | 554,000,000USD | 187,000,000USD | 2,137,000,000USD |
| Effect Of Forex Changes On Cash | 85,000,000USD | 68,000,000USD | -45,000,000USD |
| Change In Cash | -685,000,000USD | -1,105,000,000USD | -402,000,000USD |
| End Cash Flow | 2,737,000,000USD | 2,317,000,000USD | 2,756,000,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Operating metrics
Crop Protection Price Change
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | -4 | percent | Disclosure |
Crop Protection Volume Change
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | -2 | percent | Disclosure |
| 2025-06-30 | quarter | 11 | percent | Disclosure |
| 2025-03-31 | quarter | 5 | percent | Disclosure |
| 2024-09-30 | quarter | 11 | percent | Disclosure |
Organic Sales
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 6,322,000,000 | USD | Disclosure |
| 2026-03-31 | quarter | 4,726,000,000 | USD | Disclosure |
| 2025-12-31 | quarter | 3,822,000,000 | USD | Disclosure |
| 2025-09-30 | quarter | 2,587,000,000 | USD | Disclosure |
| 2025-06-30 | quarter | 6,539,000,000 | USD | Disclosure |
| 2025-03-31 | quarter | 4,608,000,000 | USD | Disclosure |
| 2024-12-31 | quarter | 4,194,000,000 | USD | Disclosure |
| 2024-09-30 | quarter | 2,456,000,000 | USD | Disclosure |
Sales Price and Product Mix Change
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 1 | percent | Disclosure |
| 2025-12-31 | quarter | 3 | percent | Disclosure |
| 2025-09-30 | quarter | 4 | percent | Disclosure |
Sales Volume Change
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | -3 | percent | Disclosure |
| 2025-09-30 | quarter | 27 | percent | Disclosure |
| 2025-06-30 | quarter | 6 | percent | Disclosure |
| 2024-12-31 | quarter | 17 | percent | Disclosure |
| 2024-09-30 | quarter | 3 | percent | Disclosure |
Seed Price and Product Mix Change
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 3 | percent | Disclosure |
| 2025-09-30 | quarter | 4 | percent | Disclosure |
Seed Volume Change
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | -3 | percent | Disclosure |
| 2025-06-30 | quarter | 6 | percent | Disclosure |
| 2024-12-31 | quarter | 19 | percent | Disclosure |
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Segment | Crop Protection | 1,882,000,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Segment | Seed | 3,023,000,000 | USD | Disclosure |
| Q4 2025Quarterly · 2025-12-31 | Segment | Crop Protection | 2,173,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Seed | 1,737,000,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Segment | Crop Protection | 7,503,000,000 | USD | Disclosure |
| FY 2025Yearly · 2025-12-31 | Segment | Seed | 9,898,000,000 | USD | Disclosure |
| Q3 2025Quarterly · 2025-09-30 | Segment | Crop Protection | 1,701,000,000 | USD | Disclosure |
| Q3 2025Quarterly · 2025-09-30 | Segment | Seed | 917,000,000 | USD | Disclosure |
| Q2 2025Quarterly · 2025-06-30 | Segment | Crop Protection | 1,919,000,000 | USD | Disclosure |
| Q2 2025Quarterly · 2025-06-30 | Segment | Seed | 4,537,000,000 | USD | Disclosure |
| Q1 2025Quarterly · 2025-03-31 | Segment | Crop Protection | 1,710,000,000 | USD | Disclosure |
| Q1 2025Quarterly · 2025-03-31 | Segment | Seed | 2,707,000,000 | USD | Disclosure |
| Q4 2024Quarterly · 2024-12-31 | Segment | Crop Protection | 2,206,000,000 | USD | Disclosure |
| Q4 2024Quarterly · 2024-12-31 | Segment | Seed | 1,772,000,000 | USD | Disclosure |
| FY 2024Yearly · 2024-12-31 | Segment | Crop Protection | 7,363,000,000 | USD | Disclosure |
| FY 2024Yearly · 2024-12-31 | Segment | Seed | 9,545,000,000 | USD | Disclosure |
| Q3 2024Quarterly · 2024-09-30 | Segment | Crop Protection | 1,635,000,000 | USD | Disclosure |
| Q3 2024Quarterly · 2024-09-30 | Segment | Seed | 691,000,000 | USD | Disclosure |
| Q4 2023Quarterly · 2023-12-31 | Segment | Crop Protection | 2,072,000,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Segment | Seed | 1,635,000,000 | USD | Legacy provider |
| FY 2023Yearly · 2023-12-31 | Segment | Crop Protection | 7,754,000,000 | USD | Disclosure |
| FY 2023Yearly · 2023-12-31 | Segment | Seed | 9,472,000,000 | USD | Disclosure |
| FY 2022Yearly · 2022-12-31 | Segment | Crop Protection | 8,476,000,000 | USD | Disclosure |
| FY 2022Yearly · 2022-12-31 | Segment | Seed | 8,979,000,000 | USD | Disclosure |
| FY 2021Yearly · 2021-12-31 | Segment | Crop Protection | 7,253,000,000 | USD | 0001755672-24-000004 |
| FY 2021Yearly · 2021-12-31 | Segment | Seed | 8,402,000,000 | USD | 0001755672-24-000004 |
| FY 2020Yearly · 2020-12-31 | Segment | Crop Protection | 6,461,000,000 | USD | 0001755672-23-000005 |
| FY 2020Yearly · 2020-12-31 | Segment | Seed | 7,756,000,000 | USD | 0001755672-23-000005 |
| FY 2019Yearly · 2019-12-31 | Segment | Crop Protection | 6,256,000,000 | USD | 0001755672-22-000005 |
| FY 2019Yearly · 2019-12-31 | Segment | Seed | 7,590,000,000 | USD | 0001755672-22-000005 |
| Q1 2019Quarterly · 2019-03-31 | Geography | Asia Pacific | 1,459,000,000 | USD | 0001755672-19-000004 |
| Q1 2019Quarterly · 2019-03-31 | Geography | EMEA | 2,110,000,000 | USD | 0001755672-19-000004 |
| Q1 2019Quarterly · 2019-03-31 | Geography | Latin America | 469,000,000 | USD | 0001755672-19-000004 |
| Q1 2019Quarterly · 2019-03-31 | Geography | U.S.Canada | 2,250,000,000 | USD | 0001755672-19-000004 |
| Q1 2019Quarterly · 2019-03-31 | Product | Agriculture | 2,108,000,000 | USD | 0001755672-19-000004 |
| Q1 2019Quarterly · 2019-03-31 | Product | Corporate Non | 2,000,000 | USD | 0001755672-19-000004 |
| Q1 2019Quarterly · 2019-03-31 | Product | Electronics Imaging | 455,000,000 | USD | 0001755672-19-000004 |
| Q1 2019Quarterly · 2019-03-31 | Product | Industrial Biosciences | 376,000,000 | USD | 0001755672-19-000004 |
| Q1 2019Quarterly · 2019-03-31 | Product | Nutrition Health | 1,014,000,000 | USD | 0001755672-19-000004 |
| Q1 2019Quarterly · 2019-03-31 | Product | Packaging Specialty Plastics | 363,000,000 | USD | 0001755672-19-000004 |
| Q1 2019Quarterly · 2019-03-31 | Product | Safety Construction | 899,000,000 | USD | 0001755672-19-000004 |
| Q1 2019Quarterly · 2019-03-31 | Product | Transportation Advanced Polymers | 1,071,000,000 | USD | 0001755672-19-000004 |
| FY 2018Yearly · 2018-12-31 | Segment | Crop Protection | 6,445,000,000 | USD | 0001755672-21-000008 |
| FY 2018Yearly · 2018-12-31 | Segment | Seed | 7,842,000,000 | USD | 0001755672-21-000008 |
| Q1 2018Quarterly · 2018-03-31 | Geography | Asia Pacific | 1,535,000,000 | USD | 0001755672-19-000004 |
| Q1 2018Quarterly · 2018-03-31 | Geography | EMEA | 2,166,000,000 | USD | 0001755672-19-000004 |
| Q1 2018Quarterly · 2018-03-31 | Geography | Latin America | 483,000,000 | USD | 0001755672-19-000004 |
| Q1 2018Quarterly · 2018-03-31 | Geography | U.S.Canada | 2,515,000,000 | USD | 0001755672-19-000004 |
| Q1 2018Quarterly · 2018-03-31 | Product | Agriculture | 2,343,000,000 | USD | 0001755672-19-000004 |
| Q1 2018Quarterly · 2018-03-31 | Product | Corporate Non | 4,000,000 | USD | 0001755672-19-000004 |
| Q1 2018Quarterly · 2018-03-31 | Product | Electronics Imaging | 527,000,000 | USD | 0001755672-19-000004 |
| Q1 2018Quarterly · 2018-03-31 | Product | Industrial Biosciences | 406,000,000 | USD | 0001755672-19-000004 |
| Q1 2018Quarterly · 2018-03-31 | Product | Nutrition Health | 1,024,000,000 | USD | 0001755672-19-000004 |
| Q1 2018Quarterly · 2018-03-31 | Product | Packaging Specialty Plastics | 419,000,000 | USD | 0001755672-19-000004 |
| Q1 2018Quarterly · 2018-03-31 | Product | Safety Construction | 855,000,000 | USD | 0001755672-19-000004 |
| Q1 2018Quarterly · 2018-03-31 | Product | Transportation Advanced Polymers | 1,121,000,000 | USD | 0001755672-19-000004 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.